Precigen Inc. (NASDAQ:PGEN) marked $1.54 per share on Monday, down from a previous closing price of $1.57. While Precigen Inc. has underperformed by -1.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PGEN fell by -71.95%, with highs and lows ranging from $6.45 to $1.12, whereas the simple moving average fell by -39.98% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
On February 25, 2021, Stifel started tracking Precigen Inc. (NASDAQ: PGEN) recommending Buy. A report published by Wells Fargo on February 22, 2021, Initiated its previous ‘Overweight’ rating for PGEN. B. Riley Securities also rated PGEN shares as ‘Buy’, setting a target price of $10 on the company’s shares in an initiating report dated February 18, 2021. H.C. Wainwright Initiated an Buy rating on May 08, 2020, and assigned a price target of $5.
Analysis of Precigen Inc. (PGEN)
Further, the quarter-over-quarter increase in sales is 30.60%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Precigen Inc.’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -79.80% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.54M can be a very valuable indicator of volatility for PGEN stock. On a monthly basis, the volatility of the stock is set at 9.84%, whereas on a weekly basis, it is put at 7.74%, with a loss of -15.38% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.20, showing growth from the present price of $1.54, which can serve as yet another indication of whether PGEN is worth investing in or should be passed over.
How Do You Analyze Precigen Inc. Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.70%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 69.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in PGEN shares?
The recent increase in stakes in PGEN appears to be a result of several institutional investors and hedge funds increasing their positions. The Vanguard Group, Inc.’s position in PGEN has decreased by -22.94% in the first quarter. The company now owns 7,572,798 shares of the stock, with a value of $10.15 million, following the sale of -2,254,744 additional shares during the last quarter. Miller Value Partners LLC made another decreased to its shares in PGEN during the first quarter, downing its stake by -0.66%. During the last quarter, the company dropped down -42,583 additional shares for a total stake of worth $8.56 million, bringing number of shares owned by the company to 6,391,355.
During the first quarter, BlackRock Fund Advisors subtracted a -15,776 position in PGEN. Millennium Management LLC purchased an additional 2.85 million shares in the last quarter, increasing its holdings by 136.79%, now holding 4.93 million shares worth $6.61 million. At the end of the first quarter, Iridian Asset Management LLC increased its PGEN holdings by 4.35% and now holds 3.76 million PGEN shares valued at $5.04 million with the added 0.16 million shares during the period. PGEN shares are owned by institutional investors to the tune of 69.50% at present.